|
USP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.650800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.997600E-01 |
| Normal-vs-Stage2 |
8.365800E-01 |
| Normal-vs-Stage3 |
2.869000E-01 |
| Normal-vs-Stage4 |
5.550400E-01 |
| Stage1-vs-Stage2 |
6.178000E-01 |
| Stage1-vs-Stage3 |
5.251200E-01 |
| Stage1-vs-Stage4 |
3.254000E-01 |
| Stage2-vs-Stage3 |
3.886000E-01 |
| Stage2-vs-Stage4 |
6.705800E-01 |
| Stage3-vs-Stage4 |
3.277800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.073200E-01 |
| Normal-vs-AfricanAmerican |
6.640400E-01 |
| Normal-vs-Asian |
3.616000E-01 |
| Caucasian-vs-AfricanAmerican |
5.824200E-01 |
| Caucasian-vs-Asian |
3.611600E-01 |
| AfricanAmerican-vs-Asian |
4.889400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.152800E-01 |
| Normal-vs-Female |
3.808300E-02 |
| Male-vs-Female |
2.358700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.717200E-01 |
| Normal-vs-Extreme_Weight |
7.333600E-02 |
| Normal-vs-Obese |
5.649800E-01 |
| Normal-vs-Extreme_Obese |
1.880590E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.347640E-01 |
| Normal_Weight-vs-Obese |
8.601000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.728400E-01 |
| Extreme_Weight-vs-Obese |
4.145700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.050800E-01 |
| Obese-vs-Extreme_Obese |
2.892000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.533200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.049400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.133800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.710500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.350600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.496200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.860200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.732980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.143520E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.560100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.637200E-01 |
| Normal-VS-Type2 PRCC |
1.755990E-01 |
| Normal-VS-KIRP CIMP |
8.532400E-01 |
| Normal-VS-Unclassified PRCC |
7.813000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.986400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.649000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.579200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.798000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.367400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.525400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.966300E-02 |
| Normal-vs-N1 |
4.838600E-01 |
| Normal-vs-N2 |
7.826000E-01 |
| N0-vs-N1 |
5.204000E-02 |
| N0-vs-N2 |
8.035000E-01 |
| N1-vs-N2 |
5.738200E-01 |
|
|
